Cladribine (Mavenclad) for MS Approved in Europe Cladribine (Mavenclad) for MS Approved in Europe

Cladribine, which is indicated for the treatment of highly active relapsing multiple sclerosis, has been approved for use in Europe.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news